Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus.

Identifieur interne : 000B38 ( Main/Exploration ); précédent : 000B37; suivant : 000B39

GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus.

Auteurs : Danying Chen [République populaire de Chine] ; Zhifei Hou [République populaire de Chine] ; Dong Jiang [République populaire de Chine] ; Mei Zheng [République populaire de Chine] ; Guoli Li [République populaire de Chine] ; Yue Zhang [République populaire de Chine] ; Rui Li [République populaire de Chine] ; Hanxin Lin [Canada] ; Jinhong Chang [États-Unis] ; Hui Zeng [République populaire de Chine] ; Ju-Tao Guo [États-Unis] ; Xuesen Zhao [République populaire de Chine]

Source :

RBID : pubmed:31631785

Descripteurs français

English descriptors

Abstract

Interferons (IFNs) control viral infections by inducing expression of IFN-stimulated genes (ISGs) that restrict distinct steps of viral replication. We report herein that gamma-interferon-inducible lysosomal thiol reductase (GILT), a lysosome-associated ISG, restricts the infectious entry of selected enveloped RNA viruses. Specifically, we demonstrated that GILT was constitutively expressed in lung epithelial cells and fibroblasts and its expression could be further induced by type II interferon. While overexpression of GILT inhibited the entry mediated by envelope glycoproteins of SARS coronavirus (SARS-CoV), Ebola virus (EBOV) and Lassa fever virus (LASV), depletion of GILT enhanced the entry mediated by these viral envelope glycoproteins. Furthermore, mutations that impaired the thiol reductase activity or disrupted the N-linked glycosylation, a posttranslational modification essential for its lysosomal localization, largely compromised GILT restriction of viral entry. We also found that the induction of GILT expression reduced the level and activity of cathepsin L, which is required for the entry of these RNA viruses in lysosomes. Our data indicate that GILT is a novel antiviral ISG that specifically inhibits the entry of selected enveloped RNA viruses in lysosomes via disruption of cathepsin L metabolism and function and may play a role in immune control and pathogenesis of these viruses.

DOI: 10.1080/22221751.2019.1677446
PubMed: 31631785


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus.</title>
<author>
<name sortKey="Chen, Danying" sort="Chen, Danying" uniqKey="Chen D" first="Danying" last="Chen">Danying Chen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hou, Zhifei" sort="Hou, Zhifei" uniqKey="Hou Z" first="Zhifei" last="Hou">Zhifei Hou</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Jiang, Dong" sort="Jiang, Dong" uniqKey="Jiang D" first="Dong" last="Jiang">Dong Jiang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zheng, Mei" sort="Zheng, Mei" uniqKey="Zheng M" first="Mei" last="Zheng">Mei Zheng</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Li, Guoli" sort="Li, Guoli" uniqKey="Li G" first="Guoli" last="Li">Guoli Li</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zhang, Yue" sort="Zhang, Yue" uniqKey="Zhang Y" first="Yue" last="Zhang">Yue Zhang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Li, Rui" sort="Li, Rui" uniqKey="Li R" first="Rui" last="Li">Rui Li</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lin, Hanxin" sort="Lin, Hanxin" uniqKey="Lin H" first="Hanxin" last="Lin">Hanxin Lin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pathology and Laboratory Medicine, Western University , London , Ontario , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pathology and Laboratory Medicine, Western University , London , Ontario </wicri:regionArea>
<wicri:noRegion>Ontario </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chang, Jinhong" sort="Chang, Jinhong" uniqKey="Chang J" first="Jinhong" last="Chang">Jinhong Chang</name>
<affiliation wicri:level="2">
<nlm:affiliation>Baruch S. Blumberg Institute, Hepatitis B Foundation , Doylestown , PA , USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Baruch S. Blumberg Institute, Hepatitis B Foundation , Doylestown , PA </wicri:regionArea>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zeng, Hui" sort="Zeng, Hui" uniqKey="Zeng H" first="Hui" last="Zeng">Hui Zeng</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Guo, Ju Tao" sort="Guo, Ju Tao" uniqKey="Guo J" first="Ju-Tao" last="Guo">Ju-Tao Guo</name>
<affiliation wicri:level="2">
<nlm:affiliation>Baruch S. Blumberg Institute, Hepatitis B Foundation , Doylestown , PA , USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Baruch S. Blumberg Institute, Hepatitis B Foundation , Doylestown , PA </wicri:regionArea>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zhao, Xuesen" sort="Zhao, Xuesen" uniqKey="Zhao X" first="Xuesen" last="Zhao">Xuesen Zhao</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31631785</idno>
<idno type="pmid">31631785</idno>
<idno type="doi">10.1080/22221751.2019.1677446</idno>
<idno type="wicri:Area/PubMed/Corpus">000865</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000865</idno>
<idno type="wicri:Area/PubMed/Curation">000865</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000865</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000895</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000895</idno>
<idno type="wicri:Area/Ncbi/Merge">003094</idno>
<idno type="wicri:Area/Ncbi/Curation">003094</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003094</idno>
<idno type="wicri:Area/Main/Merge">000B39</idno>
<idno type="wicri:Area/Main/Curation">000B38</idno>
<idno type="wicri:Area/Main/Exploration">000B38</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus.</title>
<author>
<name sortKey="Chen, Danying" sort="Chen, Danying" uniqKey="Chen D" first="Danying" last="Chen">Danying Chen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hou, Zhifei" sort="Hou, Zhifei" uniqKey="Hou Z" first="Zhifei" last="Hou">Zhifei Hou</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Jiang, Dong" sort="Jiang, Dong" uniqKey="Jiang D" first="Dong" last="Jiang">Dong Jiang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zheng, Mei" sort="Zheng, Mei" uniqKey="Zheng M" first="Mei" last="Zheng">Mei Zheng</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Li, Guoli" sort="Li, Guoli" uniqKey="Li G" first="Guoli" last="Li">Guoli Li</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zhang, Yue" sort="Zhang, Yue" uniqKey="Zhang Y" first="Yue" last="Zhang">Yue Zhang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Li, Rui" sort="Li, Rui" uniqKey="Li R" first="Rui" last="Li">Rui Li</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lin, Hanxin" sort="Lin, Hanxin" uniqKey="Lin H" first="Hanxin" last="Lin">Hanxin Lin</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pathology and Laboratory Medicine, Western University , London , Ontario , Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pathology and Laboratory Medicine, Western University , London , Ontario </wicri:regionArea>
<wicri:noRegion>Ontario </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chang, Jinhong" sort="Chang, Jinhong" uniqKey="Chang J" first="Jinhong" last="Chang">Jinhong Chang</name>
<affiliation wicri:level="2">
<nlm:affiliation>Baruch S. Blumberg Institute, Hepatitis B Foundation , Doylestown , PA , USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Baruch S. Blumberg Institute, Hepatitis B Foundation , Doylestown , PA </wicri:regionArea>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zeng, Hui" sort="Zeng, Hui" uniqKey="Zeng H" first="Hui" last="Zeng">Hui Zeng</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Guo, Ju Tao" sort="Guo, Ju Tao" uniqKey="Guo J" first="Ju-Tao" last="Guo">Ju-Tao Guo</name>
<affiliation wicri:level="2">
<nlm:affiliation>Baruch S. Blumberg Institute, Hepatitis B Foundation , Doylestown , PA , USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Baruch S. Blumberg Institute, Hepatitis B Foundation , Doylestown , PA </wicri:regionArea>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zhao, Xuesen" sort="Zhao, Xuesen" uniqKey="Zhao X" first="Xuesen" last="Zhao">Xuesen Zhao</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing , People's Republic of China.</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Institute of Infectious disease, Beijing Ditan Hospital, Capital Medical University , Beijing </wicri:regionArea>
<wicri:noRegion>Beijing </wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Emerging microbes & infections</title>
<idno type="eISSN">2222-1751</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Cathepsin L (genetics)</term>
<term>Cathepsin L (immunology)</term>
<term>Cell Line</term>
<term>Ebolavirus (genetics)</term>
<term>Ebolavirus (physiology)</term>
<term>Hemorrhagic Fever, Ebola (genetics)</term>
<term>Hemorrhagic Fever, Ebola (immunology)</term>
<term>Hemorrhagic Fever, Ebola (virology)</term>
<term>Humans</term>
<term>Lassa Fever (genetics)</term>
<term>Lassa Fever (immunology)</term>
<term>Lassa Fever (virology)</term>
<term>Lassa virus (genetics)</term>
<term>Lassa virus (physiology)</term>
<term>Lysosomes (genetics)</term>
<term>Lysosomes (immunology)</term>
<term>Lysosomes (virology)</term>
<term>Oxidoreductases Acting on Sulfur Group Donors (genetics)</term>
<term>Oxidoreductases Acting on Sulfur Group Donors (immunology)</term>
<term>SARS Virus (genetics)</term>
<term>SARS Virus (physiology)</term>
<term>Severe Acute Respiratory Syndrome (genetics)</term>
<term>Severe Acute Respiratory Syndrome (immunology)</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
<term>Viral Envelope Proteins (genetics)</term>
<term>Viral Envelope Proteins (metabolism)</term>
<term>Virus Internalization</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Cathepsine L (génétique)</term>
<term>Cathepsine L (immunologie)</term>
<term>Ebolavirus (génétique)</term>
<term>Ebolavirus (physiologie)</term>
<term>Fièvre de Lassa (génétique)</term>
<term>Fièvre de Lassa (immunologie)</term>
<term>Fièvre de Lassa (virologie)</term>
<term>Fièvre hémorragique à virus Ebola (génétique)</term>
<term>Fièvre hémorragique à virus Ebola (immunologie)</term>
<term>Fièvre hémorragique à virus Ebola (virologie)</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Lysosomes (génétique)</term>
<term>Lysosomes (immunologie)</term>
<term>Lysosomes (virologie)</term>
<term>Oxidoreductases acting on sulfur group donors (génétique)</term>
<term>Oxidoreductases acting on sulfur group donors (immunologie)</term>
<term>Protéines de l'enveloppe virale (génétique)</term>
<term>Protéines de l'enveloppe virale (métabolisme)</term>
<term>Pénétration virale</term>
<term>Réplication virale</term>
<term>Syndrome respiratoire aigu sévère (génétique)</term>
<term>Syndrome respiratoire aigu sévère (immunologie)</term>
<term>Syndrome respiratoire aigu sévère (virologie)</term>
<term>Virus de Lassa (génétique)</term>
<term>Virus de Lassa (physiologie)</term>
<term>Virus du SRAS (génétique)</term>
<term>Virus du SRAS (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Cathepsin L</term>
<term>Oxidoreductases Acting on Sulfur Group Donors</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Cathepsin L</term>
<term>Oxidoreductases Acting on Sulfur Group Donors</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Ebolavirus</term>
<term>Hemorrhagic Fever, Ebola</term>
<term>Lassa Fever</term>
<term>Lassa virus</term>
<term>Lysosomes</term>
<term>SARS Virus</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Cathepsine L</term>
<term>Ebolavirus</term>
<term>Fièvre de Lassa</term>
<term>Fièvre hémorragique à virus Ebola</term>
<term>Lysosomes</term>
<term>Oxidoreductases acting on sulfur group donors</term>
<term>Protéines de l'enveloppe virale</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Virus de Lassa</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Cathepsine L</term>
<term>Fièvre de Lassa</term>
<term>Fièvre hémorragique à virus Ebola</term>
<term>Lysosomes</term>
<term>Oxidoreductases acting on sulfur group donors</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>Hemorrhagic Fever, Ebola</term>
<term>Lassa Fever</term>
<term>Lysosomes</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Protéines de l'enveloppe virale</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Ebolavirus</term>
<term>Virus de Lassa</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Ebolavirus</term>
<term>Lassa virus</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Fièvre de Lassa</term>
<term>Fièvre hémorragique à virus Ebola</term>
<term>Lysosomes</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Hemorrhagic Fever, Ebola</term>
<term>Lassa Fever</term>
<term>Lysosomes</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Cell Line</term>
<term>Humans</term>
<term>Virus Internalization</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Pénétration virale</term>
<term>Réplication virale</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Interferons (IFNs) control viral infections by inducing expression of IFN-stimulated genes (ISGs) that restrict distinct steps of viral replication. We report herein that gamma-interferon-inducible lysosomal thiol reductase (GILT), a lysosome-associated ISG, restricts the infectious entry of selected enveloped RNA viruses. Specifically, we demonstrated that GILT was constitutively expressed in lung epithelial cells and fibroblasts and its expression could be further induced by type II interferon. While overexpression of GILT inhibited the entry mediated by envelope glycoproteins of SARS coronavirus (SARS-CoV), Ebola virus (EBOV) and Lassa fever virus (LASV), depletion of GILT enhanced the entry mediated by these viral envelope glycoproteins. Furthermore, mutations that impaired the thiol reductase activity or disrupted the N-linked glycosylation, a posttranslational modification essential for its lysosomal localization, largely compromised GILT restriction of viral entry. We also found that the induction of GILT expression reduced the level and activity of cathepsin L, which is required for the entry of these RNA viruses in lysosomes. Our data indicate that GILT is a novel antiviral ISG that specifically inhibits the entry of selected enveloped RNA viruses in lysosomes
<i>via</i>
disruption of cathepsin L metabolism and function and may play a role in immune control and pathogenesis of these viruses.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
<li>République populaire de Chine</li>
<li>États-Unis</li>
</country>
<region>
<li>Pennsylvanie</li>
</region>
</list>
<tree>
<country name="République populaire de Chine">
<noRegion>
<name sortKey="Chen, Danying" sort="Chen, Danying" uniqKey="Chen D" first="Danying" last="Chen">Danying Chen</name>
</noRegion>
<name sortKey="Hou, Zhifei" sort="Hou, Zhifei" uniqKey="Hou Z" first="Zhifei" last="Hou">Zhifei Hou</name>
<name sortKey="Jiang, Dong" sort="Jiang, Dong" uniqKey="Jiang D" first="Dong" last="Jiang">Dong Jiang</name>
<name sortKey="Li, Guoli" sort="Li, Guoli" uniqKey="Li G" first="Guoli" last="Li">Guoli Li</name>
<name sortKey="Li, Rui" sort="Li, Rui" uniqKey="Li R" first="Rui" last="Li">Rui Li</name>
<name sortKey="Zeng, Hui" sort="Zeng, Hui" uniqKey="Zeng H" first="Hui" last="Zeng">Hui Zeng</name>
<name sortKey="Zhang, Yue" sort="Zhang, Yue" uniqKey="Zhang Y" first="Yue" last="Zhang">Yue Zhang</name>
<name sortKey="Zhao, Xuesen" sort="Zhao, Xuesen" uniqKey="Zhao X" first="Xuesen" last="Zhao">Xuesen Zhao</name>
<name sortKey="Zheng, Mei" sort="Zheng, Mei" uniqKey="Zheng M" first="Mei" last="Zheng">Mei Zheng</name>
</country>
<country name="Canada">
<noRegion>
<name sortKey="Lin, Hanxin" sort="Lin, Hanxin" uniqKey="Lin H" first="Hanxin" last="Lin">Hanxin Lin</name>
</noRegion>
</country>
<country name="États-Unis">
<region name="Pennsylvanie">
<name sortKey="Chang, Jinhong" sort="Chang, Jinhong" uniqKey="Chang J" first="Jinhong" last="Chang">Jinhong Chang</name>
</region>
<name sortKey="Guo, Ju Tao" sort="Guo, Ju Tao" uniqKey="Guo J" first="Ju-Tao" last="Guo">Ju-Tao Guo</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B38 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000B38 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:31631785
   |texte=   GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:31631785" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021